Time Constraints in Diabetes Care: A Growing Crisis in Europe

A report published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) highlights a critical issue in diabetes care across Europe: the insufficient consultation time that people with diabetes receive from General Practitioners (GPs). This significant barrier is increasingly linked to poorer health outcomes, contributing to higher rates of complications and rising healthcare costs. […]

Sign the Pledge

The European Federation of Pharmaceutical Industries’ (Efpia) and European Diabetes Forum (EUDF), have published a document calling on candidates at the 2024 European Election to sign and pledge to support its contents. Around 60 percent of all European citizens come under the European Union and will have a vote in the elections. With the exception […]